Iziar Amaia
Ludwig Sanz Orrio
Profesional Investigadora
Publikationen, an denen er mitarbeitet Iziar Amaia Ludwig Sanz Orrio (2)
2023
-
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer
Nature Communications, Vol. 14, Núm. 1
2022
-
Trimethylamine N-oxide (TMAO) drives insulin resistance and cognitive deficiencies in a senescence accelerated mouse model
Mechanisms of Ageing and Development, Vol. 204